SNT Trading Halt 18/10/22 PRICE SENSITIVE download Created with Sketch. 372.8KB Share SNT Proposed Issue of Securities to Chief Executive Officer 18/10/22 download Created with Sketch. 159.29KB Share SNT Notification regarding unquoted securities - PXS 18/10/22 download Created with Sketch. 26.59KB Share SNT Investor Presentation Interim Data from Skin Scarring Study 26/09/22 download Created with Sketch. 1MB Share SNT PXS Releases Promising Interim Data from Skin Scarring Study 26/09/22 PRICE SENSITIVE download Created with Sketch. 182.78KB Share SNT Date of Virtual AGM and Date for Director Nominations 13/09/22 download Created with Sketch. 178.58KB Share SNT Investor presentation 06/09/22 download Created with Sketch. 1.05MB Share SNT Application for quotation of securities - PXS 01/09/22 download Created with Sketch. 24.91KB Share SNT PXS to Receive Stg2.9m from Parkinsons UK for New Trial 01/09/22 PRICE SENSITIVE download Created with Sketch. 208.6KB Share SNT Preliminary Final Report 30/08/22 PRICE SENSITIVE download Created with Sketch. 859.7KB Share SNT Change of Director's Interest Notice 23/08/22 download Created with Sketch. 144.17KB Share SNT Notification of cessation of securities - PXS 23/08/22 download Created with Sketch. 21.68KB Share SNT Notification of cessation of securities - PXS 22/08/22 download Created with Sketch. 21.51KB Share SNT Pharmaxis Receives Aptar Option Exercise Fees of US$5m 16/08/22 download Created with Sketch. 108.87KB Share SNT Final Director's Interest Notice 05/08/22 download Created with Sketch. 113.2KB Share SNT Director Appointment/Resignation 05/08/22 download Created with Sketch. 114.52KB Share SNT Aptar Pharma Pays PXS Us$5m to Acquire Orbital Technology 04/08/22 PRICE SENSITIVE download Created with Sketch. 167.45KB Share SNT Investor presentation for quarterly shareholder update 29/07/22 download Created with Sketch. 916.85KB Share SNT Investor presentation 29/07/22 download Created with Sketch. 1.86MB Share SNT Quarterly Activities/Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 471.83KB Share SNT Quarterly Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 199.5KB Share SNT Pharmaxis Quarterly Shareholder Update and Investor Briefing 26/07/22 download Created with Sketch. 122.24KB Share SNT Results of Meeting 11/07/22 download Created with Sketch. 177.38KB Share SNT Notification regarding unquoted securities - PXS 01/07/22 download Created with Sketch. 25.28KB Share SNT Appointment of Dr Jana Baskar as Chief Medical Officer 01/07/22 download Created with Sketch. 108.88KB Share SNT Application for quotation of securities - PXS 15/06/22 download Created with Sketch. 24.94KB Share SNT Notice of General Meeting/Proxy Form 08/06/22 download Created with Sketch. 322.61KB Share SNT Application for quotation of securities - PXS 30/05/22 download Created with Sketch. 24.92KB Share SNT Application for quotation of securities - PXS 30/05/22 download Created with Sketch. 24.94KB Share SNT Notification of cessation of securities - PXS 30/05/22 download Created with Sketch. 21.52KB Share SNT Clarification Announcement 13/05/22 PRICE SENSITIVE download Created with Sketch. 305.36KB Share SNT Investor Presentation 29/04/22 download Created with Sketch. 934.36KB Share SNT Quarterly Activities Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 496.87KB Share SNT Appendix 4C Quarterly Cash Flow Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 193.55KB Share SNT Pharmaxis Quarterly Investor Briefing 26/04/22 download Created with Sketch. 126.62KB Share SNT R&D Showcase Presentations Webinar 2 31/03/22 download Created with Sketch. 4.78MB Share SNT R&D Showcase Presentations Webinar 1 29/03/22 download Created with Sketch. 9.81MB Share SNT Investor Presentation 22/03/22 download Created with Sketch. 2.02MB Share SNT PXS Investor R&D Showcase Webinars 18/03/22 download Created with Sketch. 122.17KB Share SNT PXS Launches New International Trial Sites in Cancer Trial 17/03/22 download Created with Sketch. 117.79KB Share SNT Change in substantial holding 11/02/22 download Created with Sketch. 231.94KB Share SNT Half Yearly Report and Accounts 11/02/22 PRICE SENSITIVE download Created with Sketch. 402.94KB Share SNT Updated Investor Presentation 31/01/22 download Created with Sketch. 1.86MB Share SNT Presentation - quarterly investor update 31/01/22 download Created with Sketch. 1.05MB Share SNT Quarterly Activities Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 529.16KB Share SNT Quarterly Appendix 4C Cash Flow Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 193.78KB Share SNT First Patients Dosed in PXS Scar Reduction Trial 31/01/22 download Created with Sketch. 139.82KB Share SNT PXS Quarterly Shareholder Update and Investor Briefing 27/01/22 download Created with Sketch. 127.63KB Share SNT Response to ASX Aware Query 10/01/22 PRICE SENSITIVE download Created with Sketch. 392.67KB Share SNT PXS Collaborators Receive Government Grants of $1.4m 06/01/22 PRICE SENSITIVE download Created with Sketch. 156.38KB Share SNT Change of Director's Interest Notice 24/12/21 download Created with Sketch. 145.21KB Share SNT Change of Director's Interest Notice 23/12/21 download Created with Sketch. 140.98KB Share SNT Change of Director's Interest Notice 23/12/21 download Created with Sketch. 143.2KB Share SNT Application for quotation of securities - PXS 22/12/21 download Created with Sketch. 25.34KB Share SNT Change of Director's Interest Notice 22/12/21 download Created with Sketch. 144.71KB Share SNT Change of Director's Interest Notice 22/12/21 download Created with Sketch. 143.53KB Share SNT Application for quotation of securities - PXS 21/12/21 download Created with Sketch. 23.1KB Share SNT Share Purchase Plan 20/12/21 PRICE SENSITIVE download Created with Sketch. 145.24KB Share SNT Investor presentation 08/12/21 download Created with Sketch. 2.13MB Share SNT Investor Briefing 02/12/21 download Created with Sketch. 104.42KB Share SNT Application for quotation of securities - PXS 30/11/21 download Created with Sketch. 24.93KB Share SNT Security Purchase Plan 25/11/21 PRICE SENSITIVE download Created with Sketch. 389.6KB Share SNT Section 708A(5)(e) Notice 24/11/21 download Created with Sketch. 140.75KB Share SNT Application for quotation of securities - PXS 24/11/21 download Created with Sketch. 24.59KB Share SNT Application for quotation of securities - PXS 23/11/21 download Created with Sketch. 23.37KB Share SNT Proposed issue of securities - PXS 18/11/21 download Created with Sketch. 27.83KB Share SNT Investor Presentation 17/11/21 PRICE SENSITIVE download Created with Sketch. 2.22MB Share SNT Proposed issue of securities - PXS 17/11/21 download Created with Sketch. 24.66KB Share SNT Placement 17/11/21 PRICE SENSITIVE download Created with Sketch. 152.6KB Share SNT Trading Halt 15/11/21 PRICE SENSITIVE download Created with Sketch. 228.42KB Share SNT FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study 09/11/21 PRICE SENSITIVE download Created with Sketch. 118.69KB Share SNT Notification regarding unquoted securities - PXS 05/11/21 download Created with Sketch. 26.7KB Share SNT Investor Presentation 04/11/21 download Created with Sketch. 1.96MB Share SNT Change of Director's Interest Notice 03/11/21 download Created with Sketch. 139.49KB Share SNT Notification regarding unquoted securities - PXS 03/11/21 download Created with Sketch. 25.58KB Share SNT Constitution as amended 3 November 03/11/21 download Created with Sketch. 344.96KB Share SNT Results of Meeting 03/11/21 download Created with Sketch. 276.84KB Share SNT CEO Presentation to 2021 AGM 03/11/21 download Created with Sketch. 1.41MB Share SNT Chairman's Address to Shareholders 03/11/21 download Created with Sketch. 160.48KB Share SNT Investor Presentation - September Quarterly Update 28/10/21 download Created with Sketch. 1.15MB Share SNT Quarterly Activities Report 28/10/21 PRICE SENSITIVE download Created with Sketch. 514.55KB Share SNT Appendix 4C Cash Flow Report 28/10/21 PRICE SENSITIVE download Created with Sketch. 193.16KB Share SNT Pharmaxis Quarterly Shareholder Update and Investor Briefing 25/10/21 download Created with Sketch. 129.28KB Share SNT PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial 13/10/21 PRICE SENSITIVE download Created with Sketch. 116.37KB Share SNT PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial 05/10/21 PRICE SENSITIVE download Created with Sketch. 165.64KB Share SNT Corporate Governance Statement 01/10/21 download Created with Sketch. 237.25KB Share SNT Appendix 4G 01/10/21 download Created with Sketch. 199.5KB Share SNT Notice of Annual General Meeting/Proxy Form 01/10/21 download Created with Sketch. 492.58KB Share SNT Annual Report to shareholders 01/10/21 download Created with Sketch. 855.28KB Share SNT Change in substantial holding 27/09/21 download Created with Sketch. 421.76KB Share SNT Change in substantial holding 24/09/21 download Created with Sketch. 981.14KB Share SNT Pharmaxis to Present at Biotech Webinar 22/09/21 download Created with Sketch. 95.03KB Share SNT Application for quotation of securities - PXS 21/09/21 download Created with Sketch. 31.68KB Share SNT Notification of cessation of securities - PXS 20/09/21 download Created with Sketch. 21.62KB Share SNT Application for quotation of securities - PXS 20/09/21 download Created with Sketch. 24.93KB Share SNT Application for quotation of securities - PXS 09/09/21 download Created with Sketch. 24.93KB Share SNT Investor Presentation 07/09/21 download Created with Sketch. 1.65MB Share SNT Pharmaxis Treatment to Prevent Wound and Burns Scars Clears 31/08/21 PRICE SENSITIVE download Created with Sketch. 133.42KB Share SNT Application for quotation of securities - PXS 26/08/21 download Created with Sketch. 27.98KB Share SNT Application for quotation of securities - PXS 20/08/21 download Created with Sketch. 24.93KB Share
(20min delay)
